| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advocating for inclusive respiratory syncytial virus vaccine trials to address health disparities
|
Harboe, Zitta Barrella
|
|
|
24 |
8 |
p. e479
|
artikel
|
| 2 |
A new tool for accelerating tuberculosis vaccine development
|
Jeyanathan, Mangalakumari
|
|
|
24 |
8 |
p. 803-804
|
artikel
|
| 3 |
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial
|
Pollock, Katrina M
|
|
|
24 |
8 |
p. 829-844
|
artikel
|
| 4 |
A persistent vesiculo-pustular rash, eosinophilia, and itchy parents: think of scabies
|
Dimech, Yana Marie
|
|
|
24 |
8 |
p. e539
|
artikel
|
| 5 |
A reference standard for urinary tract infection research: a multidisciplinary Delphi consensus study
|
Bilsen, Manu P
|
|
|
24 |
8 |
p. e513-e521
|
artikel
|
| 6 |
Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study
|
Walker, Morgan K
|
|
|
24 |
8 |
p. 856-867
|
artikel
|
| 7 |
Carbapenem use in US hospitals: guidance and stewardship
|
Ernst, Erika J
|
|
|
24 |
8 |
p. 798-799
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2021; 21: e375–86
|
|
|
|
24 |
8 |
p. e485
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2024; published online Feb 9. https://doi.org/10.1016/S1473-3099(23)00731-4
|
|
|
|
24 |
8 |
p. e485
|
artikel
|
| 10 |
Early life respiratory syncytial virus disease—a preventable burden
|
Cohen, Cheryl
|
|
|
24 |
8 |
p. 794-795
|
artikel
|
| 11 |
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
|
Ares-Gómez, Sonia
|
|
|
24 |
8 |
p. 817-828
|
artikel
|
| 12 |
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial
|
Lyke, Kirsten E
|
|
|
24 |
8 |
p. 896-908
|
artikel
|
| 13 |
Escalating mpox epidemic in DR Congo
|
Boisson-Walsh, Alix
|
|
|
24 |
8 |
p. e487
|
artikel
|
| 14 |
Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality
|
Russcher, Anne
|
|
|
24 |
8 |
p. e475-e476
|
artikel
|
| 15 |
Gavi, the Vaccine Alliance supports rabies vaccination
|
Burki, Talha
|
|
|
24 |
8 |
p. e491-e492
|
artikel
|
| 16 |
Getting treated for multidrug-resistant tuberculosis
|
Bagcchi, Sanjeet
|
|
|
24 |
8 |
p. 814
|
artikel
|
| 17 |
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
24 |
8 |
p. 868-895
|
artikel
|
| 18 |
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
|
Chang, Christina C
|
|
|
24 |
8 |
p. e495-e512
|
artikel
|
| 19 |
Have we learned anything?
|
The Lancet Infectious Diseases,
|
|
|
24 |
8 |
p. 793
|
artikel
|
| 20 |
H5N1 avian influenza: tracking outbreaks with real-time epidemiological data
|
Branda, Francesco
|
|
|
24 |
8 |
p. e480-e481
|
artikel
|
| 21 |
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial
|
Pan, Hong-Xing
|
|
|
24 |
8 |
p. 922-934
|
artikel
|
| 22 |
Immunological responses in a Chlamydia trachomatis vaccine trial
|
Huston, Wilhelmina
|
|
|
24 |
8 |
p. 795-796
|
artikel
|
| 23 |
Infectious disease surveillance update
|
Pascal, Genevieve
|
|
|
24 |
8 |
p. e493
|
artikel
|
| 24 |
Is there a need for an alternative varicella vaccine?
|
Dagnew, Alemnew F
|
|
|
24 |
8 |
p. 804-806
|
artikel
|
| 25 |
John Sever
|
Bagcchi, Sanjeet
|
|
|
24 |
8 |
p. 809
|
artikel
|
| 26 |
Lessons for dengue vaccines from a human challenge study
|
Ooi, Eng Eong
|
|
|
24 |
8 |
p. 801-803
|
artikel
|
| 27 |
Lise Musset— studying antimalarial resistance in America
|
Kazi, Farooq
|
|
|
24 |
8 |
p. 811
|
artikel
|
| 28 |
Long COVID and SARS-CoV-2 persistence: new answers, more questions
|
Buonsenso, Danilo
|
|
|
24 |
8 |
p. 796-798
|
artikel
|
| 29 |
Mallika Imwong—championing malaria genomics
|
Samarasekera, Udani
|
|
|
24 |
8 |
p. 810
|
artikel
|
| 30 |
Managing diarrhoea in Guatemala's Mayan communities
|
Adhikari, Bipin
|
|
|
24 |
8 |
p. 815
|
artikel
|
| 31 |
Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions
|
Allan-Blitz, Lao-Tzu
|
|
|
24 |
8 |
p. e532-e538
|
artikel
|
| 32 |
Modelling molecular and culture-based surveillance of tetracycline resistance in Neisseria gonorrhoeae
|
Roster, Kirstin I Oliveira
|
|
|
24 |
8 |
p. 806-808
|
artikel
|
| 33 |
Naomi Lucchi—from malaria to pandemic preparedness
|
Kirby, Tony
|
|
|
24 |
8 |
p. 812
|
artikel
|
| 34 |
Outbreaks compound Brazil's flooding disaster
|
Kirby, Tony
|
|
|
24 |
8 |
p. e490
|
artikel
|
| 35 |
Poor leadership or institutional flaws?
|
Sherwood-Martin, Hollie
|
|
|
24 |
8 |
p. 816
|
artikel
|
| 36 |
Preparedness for emerging epidemic threats: detection of Oropouche circulation in Cuba
|
Toledo, Maria Eugenia
|
|
|
24 |
8 |
p. e484
|
artikel
|
| 37 |
Profiling the SARS-CoV-2-specific T-cell response
|
Geers, Daryl
|
|
|
24 |
8 |
p. e477-e478
|
artikel
|
| 38 |
Reflecting on the cost of recurrent conflicts for the USA
|
Bisbas, Georgia
|
|
|
24 |
8 |
p. 813
|
artikel
|
| 39 |
Research in brief
|
Venkatesan, Priya
|
|
|
24 |
8 |
p. e494
|
artikel
|
| 40 |
Rising measles cases in Europe—a threat to children
|
Das, Manjulika
|
|
|
24 |
8 |
p. e489
|
artikel
|
| 41 |
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
|
Satti, Iman
|
|
|
24 |
8 |
p. 909-921
|
artikel
|
| 42 |
Second malaria vaccine reaches Central African Republic
|
Bagcchi, Sanjeet
|
|
|
24 |
8 |
p. e488
|
artikel
|
| 43 |
Survival analysis of patients with cholera admitted to treatment centres in Lusaka, Zambia
|
Mbewe, Nyuma
|
|
|
24 |
8 |
p. e473-e474
|
artikel
|
| 44 |
The continuing challenge of infectious diseases
|
Keddy, Karen H
|
|
|
24 |
8 |
p. 800-801
|
artikel
|
| 45 |
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
|
Zuo, Wenting
|
|
|
24 |
8 |
p. 845-855
|
artikel
|
| 46 |
Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants
|
Kaku, Yu
|
|
|
24 |
8 |
p. e482-e483
|
artikel
|
| 47 |
40 years of Helicobacter pylori
|
Samarasekera, Udani
|
|
|
24 |
8 |
p. e486
|
artikel
|
| 48 |
Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control
|
Kang, Mei
|
|
|
24 |
8 |
p. e522-e531
|
artikel
|
Tijdschrift beschrijving